These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1734568)
21. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678 [TBL] [Abstract][Full Text] [Related]
22. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy. Zhang Y; Ma QY; Dang CX; Moureau-Zabotto M; Chen WK Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):505-11. PubMed ID: 16257133 [TBL] [Abstract][Full Text] [Related]
23. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
24. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770 [TBL] [Abstract][Full Text] [Related]
25. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Kuru B; Bozgul M Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505 [TBL] [Abstract][Full Text] [Related]
26. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma. Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593 [TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
28. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes. Orr RK; Col NF; Kuntz KM Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611 [TBL] [Abstract][Full Text] [Related]
29. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation. Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842 [TBL] [Abstract][Full Text] [Related]
30. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor. Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485 [TBL] [Abstract][Full Text] [Related]
31. Occult breast carcinoma presenting with axillary lymph node metastases. Medina-Franco H; Urist MM Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889 [TBL] [Abstract][Full Text] [Related]
32. A ten year study of medullary carcinoma of the breast. Maier WP; Rosemond GP; Goldman LI; Kaplan GF; Tyson RR Surg Gynecol Obstet; 1977 May; 144(5):695-8. PubMed ID: 850851 [TBL] [Abstract][Full Text] [Related]
33. Axillary node status in nonpalpable breast cancer. Dowlatshahi K; Snider HC; Kim R Ann Surg Oncol; 1995 Sep; 2(5):424-8. PubMed ID: 7496837 [TBL] [Abstract][Full Text] [Related]
34. [Occult cancer as a special form of breast carcinoma]. Montoro AF; Ferreira CA; Montoro FF; Monteiro DC AMB Rev Assoc Med Bras; 1990; 36(3-4):124-7. PubMed ID: 1965921 [TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of carcinoma of the breast: IV. Prognosis according to extent of involvement of the axillary lymph nodes. Lee YT; Chan LS J Surg Oncol; 1984 Sep; 27(1):35-41. PubMed ID: 6482450 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy after surgery for breast cancer--should women without axillary node involvement be candidates. Dent DM; Hacking EA; Gudgeon CA S Afr Med J; 1989 Jun; 75(11):513-4. PubMed ID: 2727837 [No Abstract] [Full Text] [Related]
37. Levamisole granulocytopenia in patients receiving an adjuvant chemoimmunotherapy program after surgery for breast carcinoma with axillary lymph node involvement. Vogel CL; Lipscomb DL; Silverman MA; Kerns AL; Mansell PW; Sugarbaker EV Cancer Treat Rep; 1978 Oct; 62(10):1587-9. PubMed ID: 709561 [No Abstract] [Full Text] [Related]
38. A prognostic index based on the mean nuclear area of breast cancer cells and efferent vascular invasion in the axillary nodes. Maehle BO; Skjaerven R Diagn Histopathol; 1983; 6(3-4):221-8. PubMed ID: 6676076 [TBL] [Abstract][Full Text] [Related]
39. A thirty year study of breast cancer in a consecutive series of private patients. Is axillary nodal study a valuable index in prognosis? McLaughlin CW; Coe JD; Adwers JR Am J Surg; 1978 Aug; 136(2):250-3. PubMed ID: 686271 [TBL] [Abstract][Full Text] [Related]
40. Palpation of the axillary nodes in breast cancer: what does the surgeon feel? Hartveit F; Skarstein A; Varhaug JE Breast Cancer Res Treat; 1988 Apr; 11(1):71-5. PubMed ID: 3382765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]